The state of Lower Saxony has been supplied with the new protein-based vaccine Nuvaxovid of the company Novavax. In addition to previous COVID-19 vaccines, the Standing Committee on Vaccination (STIKO) recommends the Novavax vaccine for primary immunisation of persons aged 18 or over. Two doses of the vaccine must be administered at an interval of at least 3 weeks.
On Thursday 10 March 2022 between 9.00 and 16.00, the vaccination centre operated by Region Hannover located in the main cafeteria at Schneiderberg (Callinstraße 23) offers vaccinations with the Novavax vaccine. On that day, vaccinations with other vaccines will not be available.
At the moment, Nuvaxovid is only approved for primary immunisation. Unvaccinated persons that have recovered from a SARS-CoV-2 infection may be vaccinated with the Nuvaxovid vaccine no earlier than 3 months after their recovery in order to complete primary immunisation. At the moment, the Nuvaxovid vaccine is not recommended for pregnant or breastfeeding women.
Currently, the Comirnaty or Spikevax vaccine is recommended for booster doses, administered at least 3 months after primary immunisation has been completed.
Information on COVID-19 vaccinations:
Information sheet for vaccinations with protein-based vaccines
Robert Koch Institute: Vaccination recommendations
Stiko recommendations
Contact information: betriebsarzt@zuv.uni-hannover.de
